Frequently Asked Questions about ProPhase Labs, Inc. (PRPH)

Name: ProPhase Labs, Inc. (PRPH) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does ProPhase Labs, Inc. (PRPH) do?

Accepted Answer

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a r...

Question 2

Is ProPhase Labs, Inc. (PRPH) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of PRPH reveals an Altman Z-Score of -3.73 and a Piotroski F-Score of 2/9. These metrics, combined with its 5-year revenue trend ($0.01B most recent), help investors decide if PRPH fits their risk profile.

Question 3

What is the current P/E ratio for PRPH?

Accepted Answer

As of the latest trading session, ProPhase Labs, Inc. (PRPH) has a trailing P/E ratio of -0.01.

Question 4

Who is the CEO of ProPhase Labs, Inc.?

Accepted Answer

The current Chief Executive Officer of ProPhase Labs, Inc. is Ted William Karkus.

Question 5

What was PRPH's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, ProPhase Labs, Inc. reported annual revenues of $0.01B (2024), $0.04B (2023), $0.12B (2022), $0.08B (2021), $0.01B (2020) respectively.

Question 6

Does PRPH pay a dividend?

Accepted Answer

ProPhase Labs, Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does PRPH have?

Accepted Answer

In its latest reporting period, ProPhase Labs, Inc. generated $-0.02B in Free Cash Flow against a total debt load of $0.02B.

Question 8

What is the Price-to-Book (P/B) ratio of ProPhase Labs, Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for ProPhase Labs, Inc. (PRPH) is currently 0.05.

Question 9

What is the Price-to-Sales (P/S) ratio of PRPH?

Accepted Answer

Based on trailing twelve-month data, ProPhase Labs, Inc. (PRPH) trades at a Price-to-Sales (P/S) ratio of 0.35.

Question 10

What is ProPhase Labs, Inc.'s Return on Equity (ROE)?

Accepted Answer

ProPhase Labs, Inc. (PRPH) has a Return on Equity (ROE) of -404.42%, representing its profitability relative to shareholder equity.

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2024-12	-17.5M	3.6M	-906K	-18.4M	-22.1M
2023-12	-11.3M	3.5M	-3.2M	-14.5M	-18M
2022-12	28.6M	4M	-3.9M	24.6M	20.6M
2021-12	-13.6M	3.2M	-4.2M	-17.9M	-21M
2020-12	-2.6M	1.5M	-1.7M	-4.3M	-5.7M

Period	Operating CF	SBC	CapEx	Free CF	True FCF
2024-12	-17.5M	3.6M	-906K	-18.4M	-22.1M
2023-12	-11.3M	3.5M	-3.2M	-14.5M	-18M
2022-12	28.6M	4M	-3.9M	24.6M	20.6M
2021-12	-13.6M	3.2M	-4.2M	-17.9M	-21M
2020-12	-2.6M	1.5M	-1.7M	-4.3M	-5.7M